Celiac disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) (Created page with "__NOTOC__ {{Celiac disease}} {{CMG}}; {{AE}} ==Overview== ==Cost-effectiveness of Therapy== ==References== {{Reflist|2}} {{WH}} {{WS}}") |
m (Bot: Removing from Primary care) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gastroenterology]] | |||
[[Category:Rheumatology]] | |||
[[Category:Autoimmune diseases]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Malnutrition]] | |||
[[Category:Pediatrics]] | |||
[[Category:Dermatology]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 20:50, 29 July 2020
|
Celiac disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Celiac disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Celiac disease cost-effectiveness of therapy |
|
Risk calculators and risk factors for Celiac disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: